1. Bristol-Myers gets breakthrough status for Opdivo-Yervoy combo in liver cancer — Roche SMA trial of risdiplam hits target— AbbVie submits sNDA for Imbruvica/Rituximab combo for CLL — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

2 more PIPS Issued in the West

Discussion in 'Sage Therapeutics' started by anonymous, Jul 23, 2019 at 8:28 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Total bullshit. Go away troll
     
  2. anonymous

    anonymous Guest

    Let’s stop talking about mommas & start helping these mommas get on therapy to treat this made up disease
     
  3. anonymous

    anonymous Guest

    You like all the managers out west? You must be crazy. If you like Coktoasten then you are part of the problem. Do us all a favor and leave.